Biosimilars Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Biosimilars Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Increasing Adoption of Biosimilars in the Healthcare Industry Drives Revenue
• High Manufacturing Costs Pose Challenges for Market Growth

The global biosimilars market is on a remarkable growth trajectory during forecast period. It is expected to reach a substantial size of US$ 98 billion by the end of 2031, up from the current industry value of US$ 34 billion.

Market Dynamics

Biosimilars, biologically similar alternatives to existing biologics, are gaining increasing adoption in the healthcare industry. They are used to prevent and treat various chronic diseases, including cancer, diabetes, autoimmune diseases, cardiovascular diseases, and infectious diseases. The rising prevalence of these healthcare issues, coupled with the economic advantages of biosimilars over traditional biologics, is driving market growth.

Revenue Generators
• Growing Adoption of Biosimilars: Increasing awareness and preference for biosimilars, along with their cost-effectiveness, are major revenue drivers. Biosimilars are particularly vital in addressing chronic diseases, and their adoption is expected to continue rising globally.
• Increased Organizational Initiatives: Public and private organizations are actively promoting the use of biosimilars over synthetic drug products and conventional biologics, fostering revenue generation opportunities for biosimilar manufacturers. The rapid expansion of the pharmaceutical sector and rising prices of existing biological drugs are further propelling growth.

Challenges Hindering Sales Growth
• High Manufacturing Costs: The production cost of biosimilars remains relatively high, posing challenges for mass production. Additionally, the complexity of the production process and the rigorous regulatory scrutiny required for biosimilars limit growth opportunities. Ensuring biosimilarity through extensive analytical characterization and regulatory approval procedures can be time-consuming and costly.

Market Trends and Opportunities
• Discounted Prices: The trend of discounted biosimilar prices, offering substantial benefits to patients, is expected to persist. Manufacturers are increasingly offering price reductions and heavy discounts, driving global biosimilars market growth.
• Strategic Collaborations: Leading manufacturers are focusing on collaborations and outsourcing production of biosimilar products, which is expected to favor market expansion. Multiple production volumes and production on different scales are being explored for potential profitability.

Regional Analysis
• Europe and North America: Europe has traditionally been the largest market for biosimilars, followed by North America. However, the biosimilars industry is witnessing significant growth in Asia, particularly in countries like China, India, and Korea. Favorable conditions, including skilled labor, lower manufacturing costs, and simplified regulatory measures, are driving growth in Asian markets.

Key Market Players

Prominent players in the global biosimilars market include Pfizer Inc., Eli Lilly & Company, Sandoz International GMBH, Hospira Inc., Actavis, Inc., Biocon Ltd., Amgen, Inc., Teva Pharmaceutical Industries Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Stada Arzneimittel Ag, Celltrion, Inc., Wockhardt Ltd, and Mylan, Inc.

Biosimilars Industry Research by Category

By Product Type:
• Recombinant Glycosylated Proteins
• Recombinant Non-Glycosylated Proteins

By Application:
• Hematology
• Growth Hormone Deficiency
• Oncology
• Diabetes Autoimmune
• Disease
• Others

By Distribution Channel:
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

By Region:
• North America
• Latin America
• Europe
• South Asia and Pacific
• East Asia
• Middle East and Africa



Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.